Asistent Universitar dr. TATIC AURELIA Candidat la titlul Sef de … · 2020. 2. 4. · Madry, Aurelia Tatic, Antonio Almeida, Aleksandar Savic, Sophie Park, Odile Beyne-Rauzy, Raphaël

Asistent Universitar dr. TATIC AURELIA

Candidat la titlul Sef de Lucrari pozitia 4

Disciplina Hematologie - Institutul Clinic Fundeni

Departamentul Invatamant Clinic 8

Facultatea de Medicina Generala

UMF ”Carol Davial” Bucuresti

FIŞA DE VERIFICARE PRIVIND CONFERIREA TITLULUI DE ŞEF DE LUCRĂRI

PARCURSUL PROFESIONAL

DA NU Punctaj

Maxim Autoevaluare Comisie

Studii de Masterat 3 Poziţia

profesională

actuală

Asistent universitar 2 2 Din afara învăţământului

Total punctaj 2

Pentru poziţia profesională actuală se trece ultima poziţie.

ACTIVITATEA DIDACTICĂ ŞI PROFESIONALĂ

Cărţi şi capitole în cărţi de specialitate:

Cărţi şi capitole în cărţi de specialitate DA/Nr. NU Punctaj

Alocat Autoevaluare Comisie

Tratat in edituri internationale – coordonator (sub

redactia)

24 x Nr

Capitol in tratat in edituri internationale – autor unic 6 x Nr

Capitol in tratat in edituri internationale – coautor (6/nr.coautori)

x Nr

Monografie/alte carti in edituri internationale –

autor unic

18 x Nr

Monografie/alte carti in edituri internationale –

coautor

(18/nr.coautori)

x Nr

Tratat in edituri nationale – coordonator (sub

redactia)

12 x Nr

Capitol in tratat in edituri nationale – autor unic 3 x Nr

Capitol in tratat in edituri nationale – coautor (3/nr. coautori)

x Nr

Monografie/alte carti in edituri nationale – autor

unic sau prim-autor

6 x Nr 6x1=6

Monografie/alte carti in edituri nationale – co-autor (6/nr.coautori)

x Nr

6:4x3=4,5

6:8x1=0,75

Total punctaj 11,25

Standard minimal necesar: Calitatea de autor (prim autor/coautor) a unei carti (sau capitol) de specialitate (tratat, monografie, etc) la o

editura recunoscuta sau la o editura internationala, in specialitatea pentru care concureaza.

Autor monografie:

Actualitati in diagnosticul si tratamentul sindroamelor mielodisplazice - Dr. Aurelia Tatic, Prof. Dr. Daniel Coriu, Prof.

Dr. Dan Nicolae Colita, Editura Universitara „Carol Davila”, Bucuresti, 2016, ISBN 978-973-708-871-0, 107 pagini.

Coautor:

1. 3 capitole în monografie Neoplasme mieloproliferative în era moleculară-sub redacţia Conf. Dr. Daniel Coriu, Editura

Universitară „Carol Davila”, Bucure;ti, 2013, ISBN 978-973-708-647-1

Cap. 7 Leucemia neutrofilică cronică-D. Coriu, D. Coliţă, A. Tatic, S. Nicoară

Cap. 9 Neoplasme mieloide şi limfoide cu eozinofile şi anomalii PDGFRA, PDGFRB sau FGFR1-D. Coriu, D. Coliţă, S.

Nicoară, A. Tatic

Cap. 12 Neoplasme mieloproliferative neclasificabile-D. Coriu, C. Dobrea, S. Nicoară, A. Tatic

2. 1 capitol “Imagictica la bolnavi cardiac”< sub redactia Prof. Dr. Carmen Ginghina, Editura Medicala, vol VII, 2013,

ISBN:978-973-39-0749-7:

Cazul 3: Caz rar de Hipertensiune pulmonara: pacienta cu Beta-talasemie, Sferocitoza ereditara si splenectomie- S. Sipos, R.

Enache, N. Dragotoiu, A. Tatic, D. Coriu, D. Vasilache, P. Platon, Carmen Ginghina.

ACTIVITATEA DE CERCETARE

A1. Articole/studii in extenso publicate în reviste de specialitate de circulaţie internaţională recunoscute (reviste indexate ISI, cu

factor de impact) şi în reviste din ţară recunoscute de către CNCSIS (cel putin categoria B):

Articole / studii Punctaj

ISI CNCSIS Alocat pe item Autoevaluare Autoevaluare Comisie

DA/Nr NU DA/Nr NU ISI CNCSIS

3 5 4 x 3 1 x 5

Nr. total puncte 12 5 17

Standard minim: minimum 5 lucrări publicate în extenso, în ultimii 5 ani, în reviste cotate CNCSIS (A sau B) sau în reviste

internaţionale cu IF, din care minimum 2 ca autor principal (echivalare: 1 articol publicat în reviste cu IF = 4 articole publicate în

reviste naţionale cotate CNCSIS).

Articole

1. The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome

at diagnosis. Aurelia Tatic, C. Jardan, O. Georgescu, O. Stanca, M. Vasilica, S. Badelita, AM Crisan, A. Colita, D. Colita,

G. Vulcan, A. R. Lupu, I. Iosif, D.Coriu,

Revista Română de Medicină de Laborator Vol. 21, Nr. 3/4, Septembrie 2013, 343-351, ISSN 1841-6624 Impact Factor=0,171

2. Refractory anemia with ringed sideroblasts and thrombocytosis without JAK2 V617F mutation: report of three cases.

A. Tatic, M Vasilică,A. Coliţă, D. Vasilache, C. Dobrea, C. Jardan, AM Găman, AM Crişan, D. Coliţă, D. Coriu1.

Rom J Morphol Embryol 2013, Vol. 54, Nr. 4, pg. 1177–1182, ISSN (print) 1220-0522, ISSN (on-line) 2066–8279, Impact

Factor=0,620

3. Epidemiological data from the registry of patients with myelodysplastic syndrome in a single hospital center of

Romania, Radu Gologan, Daniela Georgescu, Aurelia Tatic, Ioana Radulescu, Didona Vasilache

Leukemia Research 33 (2009) 1556–1561 Leukemia Research, Vol. 33, Issue 11, p1556–1561, Published online: March 7 2011,

Impact Factor 2,35 4. The impact of epidemiologic factors, hematologic factors and various regimens on the survival of a group of

myelodysplastic patients diagnosed according to FAB criteria. A. Tatic, A. Jercan, N. Dobrete, D. Vasilache, R. Gologan,

D. Coriu

Documenta Haematologica, Vol. XXXIII, No. 3-4, 2014, pg. 7-18, ISSN-1582-196X

5. Clinical case of aplastic crisis associated with extramedullary hematopoiesis in an adult with Hereditary Spherocytosis

and Parvovirus B19 Infection, Andreea Jercan, Rusu Munteanu Gina, Camelia Dobrea, Daniel Coriu, Aurelia Tatic,

Documenta Haematologica, Vol. XXXIV, No. 1-2, 2015, pg. 31-35, ISSN-1582-196X

6. Myelodysplastic Syndrome- A Case Report of Refractory Anemia With Ringed Sideroblasts, Diana Agatinei, Aurelia

Tatic, Documenta Haematologica, Vol. XXIX, No. 3-4, 2012, pg. 11-13

7. Data from registry of the patients with myelodisplastic syndrome of a single hospital center from Romania. I

Epidemiological general data and review of the literature. R. Gologan, D. Georgescu, A. Tatic, I. Radulescu, D. Vasilache,

Documenta Haematologica, Vol XXII, No. 1-2, 2009, pg. 6-14, ISSN-1582-196X

8. Data from registry of the patients with myelodisplastic syndrome from Clinicalof Hematology, Fundeni Clinical

Institute. O. Georgescu, D. Vasilache, D. Ostroveanu,V. Moraru,D. Iancu, A. Tatic, R. Gologan, Documenta Haematologica,

Vol XXII, No. 1-2, 2009, pg. 15-19, ISSN-1582-196X

A2. Brevete de inventie:

Brevete

Punctaj

Alocat pe item Autoevaluare Comisie

DA/Nr NU

1-5 x Nr

Nr. total puncte

Numarul de puncte se aloca intre 1 si 5 in functie de importanta brevetului.

Standard minim: Calitatea de deţinător a cel puţin 1 brevet de invenţie/inovaţie atestat de OSIM sau alt organism recunoscut de

certificare a proprietăţii intelectuale/industriale.

B. Studii publicate in rezumat in reviste sau in reviste si volumele unor manifestari stiintifice cu ISBN/ISSN:

. Studii publicate in forma de rezumat DA/Nr. NU Punctaj

Alocat Autoevaluare Comisie

ISI Thomson Reuters (cu factor de impact) DA 18 0,25 x Nr 0,25X22=5,5

Reviste/volumele unor manifestari stiintifice cu

ISBN/ISSN

DA 20 0,10 x Nr 0,10X16=1,6

Total punctaj 7,1

Studii publicate in rezumat in reviste sau in reviste si volumele unor manifestari stiintifice cu ISBN/ISSN:

Rezumate publicate in reviste si volumele unor manifestari stiintifice:

22 rezumate in reviste ISI

1. Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS

(EUMDS) Registry

Saskia Langemeijer, Louise De Swart, Ge Yu, Alex Smith, Simon Crouch, Tom Johnston, Pierre Fenaux, Argiris Symeonidis, Jaroslav Cermak,

Eva Hellstrom-Lindberg, Guillermo Sanz, Reinhard Stauder, Luca Malcovati, Ulrich Germing, Mette Skov Holm, Moshe Mittelman, Krzysztof

Madry, Aurelia Tatic, Antonio Almeida, Aleksandar Savic, Sophie Park, Odile Beyne-Rauzy, Raphaël Itzykson, Corine van Marrewijk, David

Bowen and Theo de Witte

Blood 2016 128:3186; Print ISSN 0006-4971, Online ISSN 1528-0020, IF 11.841

2. Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in

Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Subtitle: from the European Leukemianet MDS Registry

Marlijn Hoeks, Saskia Langemeijer, Louise De Swart, Tim Bagguley, Corine van Marrewijk, David Bowen, Jaroslav Cermak, Eva Hellstrom-

Lindberg, Aurelia Tatic, Argiris Symeonidis, Marian G.J. Van Kraaij, Panagiotis Panagiotidis, Hege Garelius, Dominic J Culligan, Marta Krejci,

Jackie Droste, Alexandra Smith, Dorine W. Swinkels and Theo de Witte

Blood 2016 128:4327; Print ISSN 0006-4971, Online ISSN 1528-0020, IF 11.841

3. P 2865 Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk

Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry.

Louise De Swart, Chloé Reiniers, Tim Bagguley, David Bowen, Jaroslav Cermak, Eva Hellström-Lindberg, Aurelia Tatic,

ArgirisSymeonidis, Gerwin Huls, Panagiotis Panagiotidis, Hege Garelius, Dominic Culligan, Marta Krejci, Corine van Marrewijk,

Jackie Droste, Alexandra Smith, Dorine W. Swinkels, Theo de Witte, Blood 126 (23), 57 th ASH, Annual Meeting Abstract Book,

December 3, 2015, pg 2865, ISSN 0006-4971, Impact Factor 10,452

4. P 1677 Prognostic Impact of Transfusions Intensity on Survival and Development of Thrombocytopenia in Newly

Diagnosed Lower-Risk MDS Patients Participating in the European Leukemianet EU-MDS Registry.

Louise De Swart, Tom Johnston, Alexandra Smith, Pierre Fenaux, Argiris Symeonidis, Jaroslav Cermak, Eva Hellström-Lindberg,

Guillermo Sanz, Reinhard Stauder, Luca Malcovati, Ulrich Germing, Gerwin Huls, Mette Skov Holm, Moshe Mittelman, Krzysztof

Madry, Aurelia Tatic, Antonio Medina Almeida, Aleksandar Savic, Sophie Park, Odile Beyne-Rauzy, Raphaël Itzykson, Corine van

Marrewijk, David Bowen, Theo de Witte

Blood 126(23), Annual Meeting Abstract December 3, 2015, pg 1677, ISSN 0006-4971, Impact Factor 10,452

5. P 243 Impact of MDS on health-related quality of life: a comparison of IPSS low-and int-1 risk MDS patients from the

European LeukemiaNet MDS (EUMDS) Registry and European reference populations.

R. Stauder,T. Bagguley, A. Smith, P. Fenaux, A. Symeonidis, J. Cermak, G. Sanz, E. Hellstrom-Lindberg, M. Mittelman, L.

Malcovati, G. Huls1, K. Mądry, U. Germing, A. Tatic, M. S. Holm, A. Savic, J. Droste, A. Guerci-Bresler, B. Slama, E. Luno, D.

Culligan, L. de Swart, W.T. Johnston, D. Bowen, T. de Witte, Haematologica

Abstract Book, 20th

Congress of the European Hematology Asssociation, Viena Austria, June 11-14, 2015, vol 100, pg 68-69, ISSN

0390-6078, Impact Factor 5,814

6.P 212 Transfusions and presence of ring sideroblasts influence hepcidin and NTBI levels in patients with lower-risk

myelodysplastic syndromes (MDS) - a report from the European LeukemiaNet MDS Registry

L. de Swart, C. Reiniers, T. Bagguley, C. Van Marrewijk, D. Bowen, J. Cermak, E. Hellström-Lindberg, A. Tatic, A.

Symeonidis, G. Huls, P. Panagiotidis, H. Garelius, D. Culligan, M. Krejci, J. Droste, A. Smith, D. Swinkels, T. de Witte,

Leukemia Research, Abstracts of the 13th International Symposium on Myelodysplastic Syndromes (MDS), 29 April 2015 - 02

May 2015, Volume 39, Supplement 1, Pages S106–S107, ISSN 0145-2126, Impact Factor: 2.351

7. 51 Prognostic impact of transfusion intensity on survival and thrombocytopenia in newly diagnosed lower-risk MDS

patients participating in The European LeukemiaNet MDS (EUMDS) Registry.

L. de Swart, W.T. Johnston, A. Smith, P. Fenaux, A. Symeonidis, J. Cermak, E. Hellström-Lindberg, G. Sanz, R. Stauder, L.

Malcovati, U. Germing, G. Huls, M.S. Holm, M. Mittelman, K. Madry, A. Tatic, A.M. Almeida, A. Savic, S. Park, O. Beyne-Rouzy,

R. Itzykson, J. Droste, D. Bowen, T. de Witte

Leukemia Research, Abstracts of the 13th International Symposium on Myelodysplastic Syndromes (MDS), 29 April 2015 - 02 May

2015, Vol. 39, S23–S24, April 2015, ISSN 0145-2126, Impact Factor: 2.351,

8. P 3267. Myelodysplastic Syndromes – Clinical Studies: Poster II Hepcidin and GDF15 Levels during the First 2 Years

Follow-up in Patients with Low and Int-1 Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS

Registry

Louise De Swart, Chloé Reiniers, Tim Bagguley, Corine van Marrewijk, David Bowen, Jaroslav Cermak, Eva Hellström-Lindberg,

Aurelia Tatic, Argiris Symeonidis, Gerwin A Huls, Alex Smith, Theo de Witte

Blood, 56 th ASH, Annual Meeting Abstract Book, December 5, 2014, 124:3267, ISSN 0006-4971, Impact Factor 10,452

9. P-167 New risk group staging according to new R-IPSS of 25 patients with low-risk MDS

Tatic, C. Jardan, O. Georgescu, O. Stanca, , 12 th International Symposium on Myelodisplastic Syndromes

Leukemia Research, May 2013, Berlin, Vol. 37Supplement 1, pg. S98-S99, ISSN 0145-2126, Impact Factor: 2.692

10. P 1101 The outcome of the adult Ph-positive acute lymphoblastic leukemia patients from an East European country in

TKIS era - the experience of Romanian Working Group for adult Acute Leukemia Study (RWGALS).

A Moicean, A Cucuianu, A Dascalescu, A Catana, E Gheorghita, A. Vasilache, S Demian, A Tatic, B Ionescu, I Ursuleac, A Ilea, A

Bojan, A Gaman, G Gaman, C Jardan, C Danaila, V Teleanu

Haematologica/16th Congress of the European Hematology Association; London, United Kingdom, Abstract Book, 2011, pg. 462,

ISSN 0390-6078, Impact Factor 6,424

11. P 1189 Treatment of B-CLL and T cell nonHodgkin lymphomas patients with Alemtuzumab; the experience of a single

romanian center.

I.Ursuleac, O.Georgescu, M.Vasilica, E. Niculescu-mizil, R. Stoia, S.Badelita, D.Coriu, AD Moicean, A.Tatic, D. Colita, R.Niculescu

Haematologica/16th Congress of the European Hematology Association; abstract book, ; London, United Kingdom, Abstract Book,

2011, pg 492-493, ISSN 0390-6078, Impact Factor 6,424

12. P 1276 Neutropenia in myelodisplastic syndromes based on the data of a single center Romanian Regystry

O. Georgescu, A. Tatic, I. Ursuleac, D. Vasilache, V. Moraru, R. Gologan

Haematologica/16th Congress of the European Hematology Association; Abstract Book, ; London, United Kingdom, Abstract Book,

2011, pg. 521, ISSN 0390-6078, Impact Factor 6,424

13. P 1289 Iron chelation therapy with deferasirox in transfusion dependent myelodysplastic syndrome patients.

M Vasilica, A Tatic, A Bardas

Haematologica/16th Congress of the European Hematology Association; Abstract Book, ; London, United Kingdom, Abstract Book,

2011, pg.525, ISSN 0390-6078, Impact Factor 6,424

14. P005 Data from the registry of the patients with myelodysplastic syndrome from Clinic of Hematology, Fundeni Clinical

Institute, Bucharest, Romania. A comparative analysis: from FAB to WHO classification

D. Vasilache, V. Moraru, D. Ostroveanu, A. Tatic, et al.

Leukemia Research, Leukemia Research, The 10th International Symposium on Myelodisplastic Syndromes, Patras, Greece,May

2009, Vol. 33Supplement 1, Pages S60-S61, ISSN 0145-2126, Impact Factor 2,358

15. P070 A diagnostic dilemma in a RARS with thrombocytosis and Jak2 negative case – case report

A. Colita, O. Georgescu, A. Tatic, A. Tuta, et al.

Leukemia Research, The 10th International Symposium on Myelodisplastic Syndromes, Patras, Greece, May 2009, Vol.

33Supplement 1, Page S100, ISSN 0145-2126, Impact Factor 2,358

16. P-033 Results of the treatment with erythropoietin in myelodysplastic syndrome in 25 patients from a single Romanian

Center.

A.. Tatic, I. Ursuleac, T. Puscariu, R. Gologan, et al., Leukemia Research, The 9th International Symposium on Myelodisplastic

Syndromes, Florence, Italy, May 16-19May, 2007, Vol. 31Supplement 1, Pages S144-S145, ISSN 0145-2126, Impact Factor 2.561

17. P 0625 Anaplastic large-cell lymphoma a retrospective multicentric clinical and pathological study.

C.Dobrea, AC Coliţă, A.Simion, D.Vasilache, V.Enache, L.Caban, A.Tatic, E.Niculescu-Mizil, O.Georgescu, M.Vasilica, AD

Moicean, I.Ursuleac, R.Stoia, D.Coriu, D.Coliţă

11th

Congress of the European Hematology Association, Amsterdam , 15 – 18 June 2006; Abstr. in Haematologica The Hematology

Journal, 2006;91(s.1), pg. 231 ISSN 0390-6078, IF 5,032

18. P 1341 Epidemiological data on myelodisplastic syndrome patient from a Romanian single center

R. Gologan, D. Georgescu, A. Tatic, I. Radulescu, D. Vasilache

11th

Congress of the European Hematology Association, Amsterdam , 15 – 18 June 2006; Abstr. in Haematologica, The Hematology

Journal, 2006;91(s.1), pg. 478, ISSN 0390-6078, IF 5,032

19. Testicle relapse of acute promyelocyte leukemia in a pacient treated with all-trans retinoic acid. E. Niculescu-Mizil, D. Ostroveanu, C.

Dobrea, A. Tatic, D. Colita, I. Sinescu

8-th Annual Congress of the European Hematology Association, Lyon, France, 12-15 june 2003, Abstr. In Hematology Journal, vol.

4-suppl. 2, june 2003 (1023)

20. P 030 Lymphoid Blast Crisis of Chronic Myeloid Leukemia

Emilia Niculescu-Mizil, D. Colita, Adriana Dumitrescu, Daniela Ostroveanu, A. Tatic, Valeria Codreanu

The 6-th Annual Meeting of the European Haemathology Association, Frankfurt, Germany, 21-24 June 2001, Abstr. In, Haematology

Journal, vol. I, Supl. I, June 2001, pg 30

21. P 031 Blast Crisis On The Start Of Chronic Myeloid Leukemia

Emilia Niculescu Mizil, Valeria Codreanu, Adriana Dumitrescu, Daniela Ostroveanu, A. Tatic

The 6-th Annual Meeting of the European Haemathology Association, Frankfurt, Germany, 21-24 June 2001, Abstr. In,

Haematology Journal, vol. I, Supl. I, June 2001, pg 30

22. P014 Haematological symptoms in the diagnosis of tuberculosis. An epidemiological study

Ostroveanu D., Niculescu-Mizil E., Varady Zs., Gioada L., Dobrea C., Tatic A

The 5th

Annual Meeting of the European Haematology Association, Birmingam, UK, 25-28 June, 2000, Abstr. in The Hematology

Journal,

16 rezumate in reviste/volumele unor manifestari stiintifice cu ISBN/ISSN:

1. Myelodisplastic syndrome-good prognostic, unfavorable outcome: a case report

Nicoleta Amalia Dobrete, Camelia Ghita, Cerasela Jardan, Camelia Dobrea, Moraru Violeta, Aurelia Tatic

5th

Interantional Conference on Myelodisplastic Syndromes, European School of Haematology, Estoril, April 14-16, 2016,

Abstract Book

2. Leucemia acuta promielocitara-recadere-optiuni terapeutice. Bogdan Ionescu, Alexandra Ghiaur, Camelia Stancioaica,

Aurelia Tatic, Daniel Coriu, Documenta Hematologica, Supliment, vol XXXV, Nr. 3-4, 2015, ISSN1582-196X

3. P29. Clinical case of aplastic crisis associated with extramedullary hematopoiesis in an adult with Hereditary

Spherocytosis and Parvovirus B19 infection, A. Jercan, G. Munteanu Rusu, C. Dobrea, D. Coriu, A. Tatic, Documenta

Haematologica, A XXIII-a Conferinta Nationala de Hematologie Clinica si Medicina Transfuzionala, 15-18 octombrie 2015,

Sinaia, Supplement 2015, pg. 48, ISSN 1582-196X

4. C9-Anemia refractara cu sideroblasti inelari si trombocitoza fara mutatia JAK2 V617F-prezentare de 3 cazuri clinice. A.

Tatic, M. Vasilica, A. Colita, D. Vasilache, C. Dobrea, C. Jardan, D. Colita, D. Coriu, Documenta Haematologica, Vol. XXX,

No. 1-2, 2013, pg. 35, ISSN-1582-196X

5. P6. Megaloblastic anemia associated with demielynating medullary disease in a vegetarian patient, A. Jercan, D. Vasilache,

C. Dobrea, G. Rusu Munteanu, A. Tatic, Documenta Haematologica, Vol XXX, No. 1-2, 2013, pg. 38, ISSN-1582-196X

6. Nodular lymphocyte predominant Hodgkin Lymphoma and T cell/ histiocyte rich B cell lymphoma-clinical,

morphological and immunophenotypical feature and their importance for differential diagnosis. A. Tatic, I. Ursuleac, C.

Dobrea, R. Stoia, E. Niculescu Mizil, B. Ionescu; Journal of Hemato-pathology, vol.1, nr. 2, 2008, pg 232. ISSN 1865-5785

7. Aspecte clinic-evolutive in Leukemia cu celule paroase intr-un lot de 73 pacienti internati in Clinica de Hematologie

Fundeni in perioada 2000-2008

Iulia Ursuleac, Lavinia Barsan, Violeta Moraru, Aurelia Tatic, Camelia Dobrea, Otilia Georgescu, Adriana Colita, Adriana

Dumitrescu

A XVII-a Conferinta Nationala de Hematologie Clinica si Transfuzionala, 2-5 octombrie 2008, Sinaia, Caiet de rezumate, pg 16-

17

8. Rezultatele tratamentului cu Imatinib mesilat (Glivec) la pacientii cu Leucemie mieloida cronica, experienta Clinicii de

Hematologie-Institutul Clinic Fundeni

Adriana Colita, D. Coriu, Alina Petruta Rosca, Iulia Ursuleac, R Niculescu, Manuela Crisan, Andreea Moicea, Emila Niculescu

Mizil, Otilia Georgescu, Mraian Vasilica, R Stoia, Leny Cban, Aristica Poenaru, Anca Popp, B Ionescu, Aurelia Tatic, Daniela

Ostroveanu, Daniela Iancu, Camelia Dobrea, Rodica Talmaci

A XVII-a Conferinta Nationala de Hematologie Clinica si Transfuzionala, 2-5 octombrie 2008, Sinaia, Caiet de rezumate, pg 17

9. Evaluarea a 55 cazuri de Leucemie mielomonocitara cronica-experienta Clinicii de Hematologie Fundeni in perioada

1977-2006.

A. Colita, I. Ursuleac, R. Gologan, A. Tatic, L. Barsan, D. Ostroveanu, C. Dobrrea, T. Puscariu, D. Iancu

Al X-lea Congres National de Hematologie, Sinaia, 4-9 oct. 2007, Caiet de rezumate, pg 71

10. Dificultati de diagnostic in limfoamele cu celule ale mantalei.

Iulia Ursuleac, A. Dumitrescu, Adriana Colita, D. Ostroveanu, C. Dobrea, Aurelia Tatic, A. Rosca, M. Schmidt.

A XVI-a Coferinta Nationala de Hematologie Clinica si Transfuzionala (cu participare internationala), Sinaia, 11-14 octombrie, 2006,

Publ. In vol. Rezumate pg. 26

11. Purpura trombocitopenica secundara cu mecanism complex (imun si indus de medicamente-Tauredon si Pegasys)–

prezentare de caz.

A. Tatic, A. Poenaru, V. Uscatescu, D Ostroveanu, L. Gheorghe, A.Ionescu, A. Colita, D. Colita

A XVI- a Conferinta Nationala de Hematologie, 21-24 septembrie , 2005, Cluj-Napoca, pg 118

12. Enterocolita necrozanta- complicatie redutabila in neutropeniile severe, prelungite.

I.Ursuleac, A. Colita, M. Schmidt, A. Rosca, A. Tatic

A XIV-a Conferinta Nationala de Hematologie Clinica si Transfuzionala 23-25 septembrie 2004, Bucuresti, Abstr. In Documenta

Haematologica vol. XIII nr. 3-4/2004, p 78

13. Proliferare mielomonocitara cronica legata de patru cazuri de leucemie acuta. Experienta personala.

Emilia Niculescu-Mizil, Daniela Ostroveanu, Camelia Dobrea, A. Tatic, D. Colita.

Congresul al IX- lea de Hematologie Clinica si Transfuzionala 2002, Caiet de rezumate, pg 29-30

14. Leucemia acuta mielo-monocitara, varianta cu eozinofile. Prezentare de caz.

Ana Berceanu, Emilia Niculescu-Mizil, Daniela Ostroveanu, Liana Gioada, I. Motoiu, Adriana Dumitrescu, A. Tatic

A XII- a Conferinta Nationala de Hematologie (cu participare internationala), 4-6 octombrie 2001, Timisoara, Volum de rezumate, pg

58

15. P 34 Limfomul malign non-hodghinian cu celula mica imunofenotip B de zona marginala tip MALT evolutiv dupa mielom

multiplu Ig M. Prezentare de caz. Emilia Niculescu-Mizil, Ileana Funduc, Camelia Dobrea, C. Vasilescu, Lidia Groza, M.

Savu, A. Tatic, S. Georgescu,D. Colita. A XI-a Conferinta Nationala de Hematologie, (cu participare internationala), Poiana

Brasov, 18-20 octombrie 2000, Caiet de rezumate, pg 17

16. P 35 A doua neoplazie asociata cu leucemia limfatica cronica, Emilia Niculescu-Mizil, Daniela Ostroveanu, Camelia Dobrea,

Zb. Varady, Anca Ion, A. Tatic, D. Colita. A XI-a Conferinta Nationala de Hematologie, (cu participare internationala), Poiana

Brasov, 18-20 octombrie 2000, Caiet de rezumate, pg 18.

C. Granturi/proiecte câştigate prin competiţie:

DA/Nr

.

NU Punctaj

Alocat Autoevaluare Comisie

Grant/proiect internaţional – director/responsabil 8 x Nr

Grant/proiect internaţional – membru în echipa de cercetare 4 x Nr

Grant/proiect naţional – director/responsabil 4 x Nr

Grant/proiect naţional – membru în echipa de cercetare 1 PNII- 41032/2007-2010: “Banca de celule stem crioprezervate pentru

cercetare si transplant autolog”, Responsabil de proiect Prof. Dr. D. Coriu

2 Grant: CEEX 42/2005-2008 –“Noi tinte celulare si moleculare in terapia

cu orientare spre pacient a tumorilor maligne. O abordare genomica si

proteomica”. “ INCD “V Babes’ partener responsabil Conf. Dr Adriana

Colita

3. PN II 172/2008. Director proiect Prof Dr Carmen Ardeleanu (INCD „V

Babes”), responsabil proiect Dr Camelia Dobrea (UMF „Carol Davila”),

2008-2011, valoare UMF-33.000 lei

Cuantificarea efectelor unor noi factori reglatori celulari si moleculari ai

micromediului asupra tolerantei imune in cursul terapiei antiinflamatoare

si/sau antitumorale

4 Grant : Contract nr.119 CEEX/CORINT, 2006-2008: “Promovarea

participarii romanesti in programele internationale de cercetare in domeniul

sindroamelor mielodisplazice”

Da

4

2 x Nr 2X4=8

Studii multicentrice internaţionale – investigator principal 1 A prospective, multicenter European Registry for newly diagnosed patients

with Myelodisplastic Syndromes of IPSS low and intermediate-1 subtypes.

Proiect de cercetare lansat in 2008 prin alianta cu European Leukemia Net

(WP8), Sponsor: Radboud University Nijmegen Medical Center

2 A Prospective Aranesp Observational Study in Patients with

Chemotherapy-Induced Anemia 2010-1014

Da

2

3 x Nr 3x2=6

Studii multicentrice internaţionale - membru în echipa de

cercetare 1 IL2 (2004-2006) Compared of the efficacy of combined therapy

(monoclonal antibodies and investigational drug) versus standard therapy

(monoclonal antibodies) in patients with follicular non-Hodkgkin’s

Lymphoma, subinvestigator

2 LYM 3001 -2006-2011, subinvestigator

3 Phase 3 Open-Label Randomized Study of Amonafide L-Malate in

Combination with Cytarabine Compared to Daunorubicin in Combination

with Cytarabine in Patients with Secundary Acute Myeloid Leukemia

(AML), 2008-2012, subinvestigator

4 Studiul CLAVELA- Studiu randomizat de faza III pentru pacientii cu

LAM a -2-a recadere sau cu LAM rezistent dupa chimioterapia de salvare,

subinvestigator

Da

4

1 x Nr 4X1=4

Studii multicentrice naţionale – investigator principal 1 MABRO 2012-dec 2015 Studiu non-interventional, post-marketing,

obsrvational, de evaluare a factorilor biologici, clinici si a factorilor de

prognostic IPI la pacientii cu DLBCL in tratament de prima linie R-CHOP

2 Study to Observe the Effetiveness of Aranesp in Anaemic Patients with

Non-Myeloid Haematological Malignanacies Receiving Myelosuppressive

Chemotherapy, 2012

Da

2

1 x Nr 2X1=2

Studii multicentrice naţionale – membru în echipa de cercetare 0,5 x Nr

Proiecte educaţionale şi de formare continuă - director 1,5 x Nr

Proiecte educaţionale şi de formare continuă – respons. 1 x Nr

Proiecte educaţionale şi de formare continuă - membru 0,5 x Nr

Total punctaj 20

Standard minimal necesar: Minim membru in echipa a cel putin unui grant/proiect, câştigat prin competiţie.

Participare la proiecte de cercetare/granturi nationale

1. PNII- 41032/2007-2010: “Banca de celule stem crioprezervate pentru cercetare si transplant autolog”, Responsabil de

proiect Prof. Dr. D. Coriu

Functia: subinvestigator

2. Grant: CEEX 42/2005-2008 –“Noi tinte celulare si moleculare in terapia cu orientare spre pacient a tumorilor maligne.

O abordare genomica si proteomica”. “ INCD “V Babes’ partener responsabil Conf. Dr Adriana Colita

Functia: subinvestigator

3. PN II 172/2008. Director proiect Prof Dr Carmen Ardeleanu (INCD „V Babes”), responsabil proiect Dr Camelia Dobrea (UMF

„Carol Davila”), 2008-2011, valoare UMF-33.000 lei- Cuantificarea efectelor unor noi factori reglatori celulari si

moleculari ai micromediului asupra tolerantei imune in cursul terapiei antiinflamatoare si/sau antitumorale

4. Grant : Contract nr.119 CEEX/CORINT, 1.08.2006-31.07.2008: “Promovarea participarii romanesti in programele

internationale de cercetare in domeniul sindroamelor mielodisplazice”

Functia: coparticipant

Studii multicentrice internaţionale – investigator principal

1. A prospective, multicenter European Registry for newly diagnosed patients with Myelodisplastic Syndromes of

IPSS low and intermediate-1 subtypes. Proiect de cercetare lansat in 2008 prin alianta cu Europen Leukemia Net

(WP8), Sponsor: Radboud University Nijmegen Medical Center,

Funtia: Investigator Principal si Coordonator

2. A Prospective Aranesp Observational Study in Patients with Chemotherapy-Induced Anemia 2010-1014

Funtia: Investigator Principal

Studii multicentrice internaţionale - membru în echipa de cercetare

1. IL2 (2004-2006) Compared of the efficacy of combined therapy (monoclonal antibodies and investigational drug)

versus standard therapy (monoclonal antibodies) in patients with follicular non-Hodkgkin’s Lymphoma,

subinvestigator

2. LYM 3001 -2006-2011, subinvestigator

3. Phase 3 Open-Label Randomized Study of Amonafide L-Malate in Combination with Cytarabine Compared to

Daunorubicin in Combination with Cytarabine in Patients with Secundary Acute Myeloid Leukemia (AML), 2008-

2012, subinvestigator

4. Studiul CLAVELA- Studiu randomizat de faza III pentru pacientii cu LAM a -2-a recadere sau cu LAM rezistent

dupa chimioterapia de salvare, subinvestigator

Participare la studii clinice nationale ca investigator principal:

1. MABRO 2012-dec 2015 Studiu non-interventional, post-marketing, obsrvational, de evaluare a factorilor biologici,

clinici si a factorilor de prognostic IPI la pacientii cu DLBCL in tratament de prima linie R-CHOP.

Functia investigator principal

2. Study to Observe the Effetiveness of Aranesp in Anaemic Patients with Non-Myeloid Haematological Malignanacies

Receiving Myelosuppressive Chemotherapy, 2012

Functia investigator principal

RECUNOAŞTEREA ŞI IMPACTUL ACTIVITĂŢII

DA/Nr NU Punctaj

Alocat pe item Autoevaluare Comisie

Citări în reviste ISI şi BDI . Epidemiological data from the registry of patients with myelodysplastic

syndrome, in a single hospital center of Romania.Leuk Res. 009;33(11):1556-1561.Gologan R, Georgescu D, Tatic A, Radulescu

I, Vasilache D

Citatii:

1. Demographic, Hematologic, and Clinical Features of Myelodysplastic

Syndrome Patients: Results from the First Polish Myelodysplastic

Syndrome Registry (Article) Mądry, K.a , Machowicz, R.a, Waszczuk-

Gajda, A.a, Drozd-Sokołowska, J.a, Dwilewicz-Trojaczek, J.a, Acta

Haematologica , Volume 134, Issue 2, 25 July 2015, Pages 125-134;

2. The impact of category, cytopathology and cytogenetics on development

and progression of clonal and malignant myeloid transformation in

inherited bone marrow failure syndromes. Cada, M., Segbefia, C.I.,

Klaassen, R., Zlateska, B., Dror, Y. Haematologica. 2015 May;100(5):633-42.

doi: 10.3324/haematol.2014.117457. Epub 2015 Feb 14.

3. Beyond race-related disparities: Is myelodysplastic syndrome the same

everywhere? Magalhaes, S.M.M., Heredia, F.F., Fernandes, L.C.M., Souza,

G.F., Pinheiro, R.F. Leukemia and Lymphoma, 54 (7), pp. 1564-1566, 2013

Da 10 0,05 x 10 0,50

4. Myelodysplastic syndrome in New Zealand and Australia Rodger, E.J.,

Morison, I.M., Internal Medicine Journal 42 (11), pp. 1235-1242, 2012

5. Incidence and survival of chronic myelomonocytic leukemia in Girona

(Spain): A population-based study, 1993-2007 Osca-Gelis, G., Puig-Vives,

M., Saez, M., Solé, F., Marcos-Gragera, R. , Leukemia Research, 36 (10)

6. Incidence and prevalence of myelodysplastic syndromes: Data from the

Düsseldorf MDS-registry Neukirchen, J., Schoonen, W.M., Strupp, C., (...),

Haas, R., Germing, U., Leukemia Research , 35 (12), pp. 1591-1596, 2011

7. Myelodysplastic syndromes (Book Chapter) Wilkins, B.S., Porwit, A.,

Blood and Bone Marrow Pathology, pp. 303-320, 2011

8. Incidence of the myelodysplastic syndromes using a novel claims-based

algorithm: High number of uncaptured cases by cancer registries Cogle,

C.R., Craig, B.M., Rollison, D.E., List, A.F. , Blood , 117 (26), pp. 7121-7125,

2011

9. Epidemiological data on myelodysplastic syndrome patients under 50

years in a single center of Romania Gologan, R. , Leukemia Research, 34

(11), pp. 1442-1446, 2010

10. Demo-geographical data of myelodysplastic syndrome based on a large

sample of patients from a Romanian Hematological Center, Gologan, R.,

Journal of B.U.ON. 15 (3), pp. 547-555, 2010

Membru in conducerea unor structuri profesional stiintifice

internationale

Membru in Steering Committee Country Coordinatory in cadrul

Registrului European de Sindrom mielodisplazic din cadrul

European Leukemia Net (WP8)

Da 1 1-4 x Nr 4

Membru in conducerea unor structuri profesional stiintifice

nationale

Country Coordinatory in cadrul Registrului European de

Da 1 1-2 x Nr 2

Sindrom mielodisplazic din cadrul European Leukemia Net

(WP8)

Membru în colective editoriale (de redactie) 1-3 x Nr

Recenzor (reviewer) pentru reviste CNCSIS (cel putin

categoria B) sau reviste cotate ISI/BDI

Documenta Haematologica

Da 1 1-2 x Nr 2

Premii/distinctii internationale 1-4 x Nr

Premii/distincţii nationale Premiul de Excelenta- MDS Academy, 30 sept-2 oct 2011,

Predeal

Premiul de Excelenta - MDS Academy, 21-23 sept 2012, Predeal

Da 2 1-2 x Nr 2x2=4

Prezentari invitate in plenul unor manifestari stiintifice

internationale

1-2 x Nr

Prezentari invitate in plenul unor manifestari stiintifice

nationale

DA

18

0,25-0,5 x Nr 18X0,25=4,5

Membru comitet de organizare manifestari stiintifice

internationale

0,10-0,50 x Nr

Membru comitet de organizare manifestari stiintifice

nationale

0,10-0,25 x Nr

Membru comisii de doctorat (exclusiv presedinte) 0,10 x Nr

Profesor invitat (exclusiv ERASMUS) 1-4 x Nr

Experienţă de management în cercetare şi/sau învăţământ 1-5 puncte (la

aprecierea

comisiei)

Participare efectivă la manifestări ştiinţifice Da 74 0,05 x Nr 0,05x74=3,7

Total punctaj 20,7

Numarul de puncte se acorda in functie de importanta.

Citatii

10 citatii articol: Epidemiological data from the registry of patients with myelodysplastic syndrome, in a single hospital center

of Romania.Leuk Res. 009;33(11):1556-1561.Gologan R, Georgescu D, Tatic A, Radulescu

I, Vasilache D:

1. Demographic, Hematologic, and Clinical Features of Myelodysplastic Syndrome Patients: Results from the First Polish

Myelodysplastic Syndrome Registry (Article) Mądry, K.a

, Machowicz, R.a, Waszczuk-Gajda, A.

a, Drozd-Sokołowska, J.

a,

Dwilewicz-Trojaczek, J.a, Acta Haematologica , Volume 134, Issue 2, 25 July 2015, Pages 125-134;

2. The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid

transformation in inherited bone marrow failure syndromes. Cada, M., Segbefia, C.I., Klaassen, R., Zlateska, B., Dror, Y.

Haematologica. 2015 May;100(5):633-42. doi: 10.3324/haematol.2014.117457. Epub 2015 Feb 14.

3. Beyond race-related disparities: Is myelodysplastic syndrome the same everywhere? Magalhaes, S.M.M., Heredia, F.F.,

Fernandes, L.C.M., Souza, G.F., Pinheiro, R.F. Leukemia and Lymphoma, 54 (7), pp. 1564-1566, 2013

4. Myelodysplastic syndrome in New Zealand and Australia Rodger, E.J., Morison, I.M., Internal Medicine Journal 42 (11), pp.

1235-1242, 2012

5. Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): A population-based study, 1993-2007 Osca-

Gelis, G., Puig-Vives, M., Saez, M., Solé, F., Marcos-Gragera, R. , Leukemia Research, 36 (10)

6. Incidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registry Neukirchen, J., Schoonen,

W.M., Strupp, C., (...), Haas, R., Germing, U., Leukemia Research , 35 (12), pp. 1591-1596, 2011

7. Myelodysplastic syndromes (Book Chapter) Wilkins, B.S., Porwit, A., Blood and Bone Marrow Pathology, pp. 303-320, 2011

8. Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: High number of uncaptured cases by

cancer registries Cogle, C.R., Craig, B.M., Rollison, D.E., List, A.F. , Blood , 117 (26), pp. 7121-7125, 2011

9. Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of Romania Gologan, R. ,

Leukemia Research, 34 (11), pp. 1442-1446, 2010

10. Demo-geographical data of myelodysplastic syndrome based on a large sample of patients from a Romanian Hematological

Center, Gologan, R.

18 Prezentari:

1. Dasatinib induce raspuns hematologic si citogenetic notabil in LMC faza cronica dupa esecul terapiei cu Imatinib, 30

martie 2007

2. Date din registrul pacienţilor cu Sindrom Mielodisplazic al Clinicii de Hematologie, Institutul Clinic Fundeni I. Date

epidemiologice generale, iunie 2007, Iasi

3. Date din registrul pacientilor cu Sindrom Sielodisplazic al Clinicii de Hematologie, Institutul Clinic Fundeni II. Date

demo-geografice, iunie 2007, Iasi

4. Rezultatele tratamentului cu Eritropoetină la pacienţii cu sindrom mielodisplazic dintr-un singur centru din România,

iunie 2007, Iasi

5. Dasatinib comparat cu Imatinib in doza mare la pacienti cu Leucemie Mieloida Cronica in faza cronica (LMC-FC)

dupa recadere cu doza standard de Imatinib – studiul START-R - rezultate la 2 ani, 4 martie 2010

6. Ajustarea dozelor de Dasatinib şi managementul efectelor adverse, 25 februarie 2010

7. Sindroame mielodisplazice diagnostic si tratament, 31 aug 2011, Sibiu

8. Prezentare caz clinic in cadrul MDS Academy, 30 sept-2 oct 2011, Predeal

9. Prezentare de caz in cadrul Conferintei Nationale de Hematologie, Sinaia 2011

10. Prezentare caz clinic in cadrul MDS Academy, 21-23 sept 2012, Predeal

11. Sindromul mielodisplazic risc scazut/intermediar-1, strategii terapeutice, mai 2012, Mamaia

12. Rolul examenului citogenetic in managementul pacientilor cu sindrom mielodispalzic, A XXI-a Conferinta Nationla de

Hematologie Clinica si Medicina Transfuzional, Sinaia, 10-13 oct. 2012

13. Utilizarea chelatorilor de fier în sindroamele mielodisplazice, Scoala de vara, Izvorani, 6 iulie 2013

14. Anemia refractara cu sideroblasti inelari si trombocitoza fara mutatia JAK2 V617F-prezentare de 3 cazuri clinice. A.

Tatic, A XXI-a Conferinta Nationla de Hematologie Clinica si Medicina Transfuzional, Sinaia, 10-13 oct. 2013

15. Profilaxia infectiilor fungice la pacientii cu hemopatii maligne, 7 august 2014, Bucuresti

16. Eficacitatea Sprycel ca tratament de linia a doua, Răspunsuri rapide, profunde şi durabile la pacienţii cu LMC-FC care

prezintă eşecintoleranţă la tratamentul anterior, 18 septembrie 2014, Bucuresti

17. Neutropenia si neutropenia febrilă: Principala limitare a intensității chimioterapiei, iunie 2015, Bucuresti

18. The Management of Anaemia in patients with Myelodysplastic Syndromes (MDS), 30 iunie 2015, Bucuresti

Punctaj total 78,05

9.01.2017